首頁 > 市場調查報告書 > 醫療設備

呼吸器

市場調查報告書

商品編碼

1789374

氧合器市場：依產品類型、患者類型、最終用戶和地區分類

Artificial Lung Market, By Product Type, By Patient Type, By End User, By Geography

出版日期: 2025年07月16日 | 出版商:

Coherent Market Insights | 英文 168 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計 2025 年人工肺市場價值將達到 21 億美元，到 2032 年將達到 41.2 億美元，2025 年至 2032 年的年複合成長率（CAGR）為 10.1%。

分析範圍		分析詳細資訊
基準年	2024	市場規模（2025年）	21億美元
效能數據	2020-2024	預測期	2025-2032
預測期間的複合年成長率（2025-2032年）	10.10%	預計金額（2032年）	41.2億美元

全球人工肺市場是更廣泛的醫療設備產業的重要部分，專注於旨在暫時或永久取代嚴重呼吸系統疾病患者的自然肺功能的先進生命維持技術。

人工肺，又稱為體外膜氧合 (ECMO) 系統或機械肺容量支持裝置，是急性呼吸窘迫症候群(ARDS)、慢性阻塞性肺病(COPD)、肺動脈栓塞和其他危及生命的呼吸衰竭患者的重要治療方案。這些先進的生物醫學設備透過為血液供氧並排放體內二氧化碳來發揮作用，有效地執行健康肺部通常進行的氣體交換功能。

該市場涵蓋各種技術方案，包括膜式氧合器、人工肺植入和穿戴式人工肺系統，每種方案均旨在滿足特定患者需求和臨床場景。由於全球呼吸系統疾病的發生率不斷上升、人口老化以及近期呼吸系統疫情的影響，人工肺市場正受到醫療保健提供者、醫療設備製造商和投資者的廣泛關注，他們正在尋求創新解決方案，以應對重症加護挑戰並改善加護治療環境中患者的預後。

市場動態

全球人工肺市場的主要驅動力在於全球呼吸系統疾病（例如慢性阻塞性肺病、急性呼吸窘迫症候群和肺纖維化）的日益普及。這些疾病影響著全球整體數百萬患者，並對先進的呼吸支援技術產生了巨大的需求。全球人口老化是市場成長的主要動力，因為老年人更容易患呼吸系統併發症，需要加護治療。同時，生物相容性材料、小型化和氣體交換效率的提高等技術進步正在提高人工肺系統的性能和安全性。

COVID-19 大流行凸顯了對呼吸支援設備的迫切需求，並加速了市場擴張，特別是由於全球對醫療基礎設施的投資增加。然而，市場成長面臨重大限制因素，包括與人工肺設備及其維護相關的極高成本、可能延遲產品發布的複雜監管核准流程，以及與這些侵入性手術相關的嚴重併發症風險，如出血、感染和血栓症形成。缺乏受過操作先進人工肺系統訓練的熟練醫療專業人員，再加上這些設備在新興市場供應有限，進一步限制了市場滲透。儘管如此，正在進行的生物醫學工程研究和開發中存在著巨大的商業機會，特別是可植入人工肺和穿戴式設備的開發，它們有可能徹底改變患者照護。

人工智慧和機器學習技術在預測性監測和自動調整方面的融合，為市場擴張提供了一條充滿希望的途徑，而新興市場醫療支出的不斷成長以及人們對先進呼吸護理解決方案的日益關注，也創造了新的成長機會。醫療設備製造商與醫療機構之間的戰略夥伴關係，以及政府支持重症加護基礎設施發展的舉措，預計將推動人工肺領域持續的市場成長和技術創新。

本報告的主要特點

本報告對全球氧合器市場進行了詳細分析，並以 2024 年為基準年，展示了預測期（2025-2032 年）的市場規模和複合年成長率。
它還強調了每個領域的潛在商機，並描述了該市場的一系列有吸引力的投資提案。
它還提供了有關市場促進因素、限制因素和機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的重要見解。
全球氧合器市場的主要企業會根據以下參數進行分析，例如公司概況、產品系列、主要亮點、財務表現和策略。
本報告的見解將使負責人和企業經營團隊能夠就未來的產品發布、合作夥伴關係、市場擴張和行銷策略做出明智的決策。
《全球人工肺市場》報告涉及該行業的各個相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
相關人員可以透過用於分析全球氧合器市場的各種策略矩陣更輕鬆地做出決策。

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	USD 2.10 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	10.10%	2032 Value Projection:	USD 4.12 Bn

Artificial lungs, also known as extracorporeal membrane oxygenation (ECMO) systems or mechanical lung support devices, serve as vital therapeutic solutions for patients suffering from acute respiratory distress syndrome (ARDS), chronic obstructive pulmonary disease (COPD), pulmonary embolism, and other life-threatening respiratory failures. These sophisticated biomedical devices function by oxygenating blood and removing carbon dioxide outside the body, effectively performing the gas exchange function typically handled by healthy lungs.

The market encompasses various technological approaches, including membrane oxygenators, artificial lung implants, and wearable artificial lung systems, each designed to address specific patient needs and clinical scenarios. With the increasing prevalence of respiratory diseases globally, aging populations, and the recent impact of respiratory pandemics, the artificial lung market has gained significant attention from healthcare providers, medical device manufacturers, and investors seeking innovative solutions to address critical care challenges and improve patient outcomes in intensive care settings.

Market Dynamics

The global artificial lung market is primarily driven by the escalating prevalence of respiratory diseases worldwide, including chronic obstructive pulmonary disease, acute respiratory distress syndrome, and pulmonary fibrosis, which collectively affect millions of patients globally and create substantial demand for advanced respiratory support technologies. The aging global population significantly contributes to market growth, as elderly individuals are more susceptible to respiratory complications and require intensive care interventions, while technological advancements in biocompatible materials, miniaturization, and improved gas exchange efficiency have enhanced the performance and safety profiles of artificial lung systems.

The COVID-19 pandemic has particularly accelerated market expansion by highlighting the critical need for respiratory support devices and increasing healthcare infrastructure investments globally. However, market growth faces considerable restraints, including the extremely high costs associated with artificial lung devices and their maintenance, complex regulatory approval processes that can delay product launches, and the significant risk of complications such as bleeding, infection, and thrombosis associated with these invasive procedures. The shortage of skilled healthcare professionals trained in operating sophisticated artificial lung systems, coupled with limited availability of these devices in developing regions, further constrains market penetration. Nevertheless, substantial opportunities exist through ongoing research and development in bioengineering, particularly in developing implantable artificial lungs and wearable devices that could revolutionize patient care.

The integration of artificial intelligence and machine learning technologies for predictive monitoring and automated adjustments presents promising avenues for market expansion, while increasing healthcare expenditure in emerging markets and growing awareness about advanced respiratory care solutions create new growth opportunities. Strategic partnerships between medical device manufacturers and healthcare institutions, along with government initiatives supporting critical care infrastructure development, are expected to drive sustained market growth and innovation in the artificial lung sector.

Key Features of the Study

This report provides in-depth analysis of the global artificial lung market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global artificial lung market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Medtronic plc, Getinge AB, LivaNova PLC, Terumo Corporation, Fresenius Medical Care AG & Co. KGaA, ALung Technologies, Inc., Breethe, Inc., Miromatrix Medical Inc., Abiomed, Inc., Cyanagen Srl, Nipro Corporation, and Hemovent GmbH
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global artificial lung market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global artificial lung market

Market Segmentation

Product Type Insights (Revenue, USD Bn, 2020 - 2032)
- Extracorporeal Membrane Oxygenation (ECMO) Systems
- Veno-Arterial (VA) ECMO
- Veno-Venous (VV) ECMO
- Paracorporeal Artificial Lungs
- Pumpless Paracorporeal Devices
- Pump-Assisted Paracorporeal Devices
- Implantable Artificial Lungs
- Intrathoracic Devices
- Vascular Graft-Integrated Devices
- Others (Oxygenators)
Technology Insights (Revenue, USD Bn, 2020 - 2032)
- Perfusion Systems
- Membrane Oxygenation Technology
- Microfluidic Oxygenators
- Biohybrid Systems
- Pumpless Gas Exchange Systems
- Others (3D-Printed Artificial Lung Constructs, etc.)
Portability Insights (Revenue, USD Bn, 2020 - 2032)
- Stationary Systems
- Portable Systems
- Wearable Systems
Application Insights (Revenue, USD Bn, 2020 - 2032)
- Lung Transplant Support (Bridge-to-Transplant)
- Acute Respiratory Distress Syndrome (ARDS)
- Chronic Respiratory Conditions (COPD, Pulmonary Hypertension, Cystic Fibrosis)
- Others (Coronary Artery Bypass Grafting, etc.)
Patient Type Insights (Revenue, USD Bn, 2020 - 2032)
- Neonates
- Pediatric
- Adult
End User Insights (Revenue, USD Bn, 2020 - 2032)
- Hospitals
- Transplant Centers
- Ambulatory Surgical Centers
- Emergency and Trauma Centers
- Home Care Settings (for wearable devices)
- Others (Research Institutes, etc.)
Regional Insights (Revenue, USD Bn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Medtronic plc
- Getinge AB
- LivaNova PLC
- Terumo Corporation
- Fresenius Medical Care AG & Co. KGaA
- ALung Technologies, Inc.
- Breethe, Inc.
- Miromatrix Medical Inc.
- Abiomed, Inc.
- Cyanagen Srl
- Nipro Corporation
- Hemovent GmbH

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Artificial Lung Market, By Product Type
- Global Artificial Lung Market, By Technology
- Global Artificial Lung Market, By Portability
- Global Artificial Lung Market, By Application
- Global Artificial Lung Market, By Patient Type
- Global Artificial Lung Market, By End User
- Global Artificial Lung Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Driver
Restraint
Opportunity
Impact Analysis
Key Developments
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Industry Trends

4. Global Artificial Lung Market, By Product Type, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Extracorporeal Membrane Oxygenation (ECMO) Systems
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  - Veno-Arterial (VA) ECMO
  - Veno-Venous (VV) ECMO
Paracorporeal Artificial Lungs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  - Pumpless Paracorporeal Devices
  - Pump-Assisted Paracorporeal Devices
Implantable Artificial Lungs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  - Intrathoracic Devices
  - Vascular Graft-Integrated Devices
Others (Oxygenators)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Artificial Lung Market, By Technology, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Perfusion Systems
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Membrane Oxygenation Technology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Microfluidic Oxygenators
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Biohybrid Systems
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Pumpless Gas Exchange Systems
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others (3D-Printed Artificial Lung Constructs, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Artificial Lung Market, By Portability, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Stationary Systems
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Portable Systems
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Wearable Systems
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Artificial Lung Market, By Application, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Lung Transplant Support (Bridge-to-Transplant)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Acute Respiratory Distress Syndrome (ARDS)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Chronic Respiratory Conditions (COPD, Pulmonary Hypertension, Cystic Fibrosis)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others (Coronary Artery Bypass Grafting, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Artificial Lung Market, By Patient Type, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Neonates
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Pediatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Adult
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Artificial Lung Market, By End User, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Transplant Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Emergency and Trauma Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Home Care Settings (for wearable devices)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others (Research Institutes, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

10. Global Artificial Lung Market, By Region, 2020 - 2032, Value (USD Bn)

Introduction
- Market Share (%) Analysis, 2025,2028 & 2032, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Portability, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Patient Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Portability, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Patient Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Portability, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Patient Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Portability, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Patient Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Portability, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Patient Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Portability, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Patient Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
  - South Africa
  - North Africa
  - Central Africa

11. Competitive Landscape

Medtronic plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Getinge AB
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
LivaNova PLC
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Terumo Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Fresenius Medical Care AG & Co. KGaA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
ALung Technologies, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Breethe, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Miromatrix Medical Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Abiomed, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Cyanagen Srl
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Nipro Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Hemovent GmbH
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies